首頁 > 市場調查報告書 > 醫療設備

生技設備

微流體免疫檢測市場規模、佔有率和成長分析（按產品、技術、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1898525

微流體免疫檢測市場規模、佔有率和成長分析（按產品、技術、應用、最終用戶和地區分類）－2026-2033年產業預測

Microfluidic Immunoassay Market Size, Share, and Growth Analysis, By Product (Consumables, Cartridges), By Technology (Electrochemical Detection, Optical Detection), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球微流體免疫檢測市場規模預計在 2024 年達到 12.9 億美元，從 2025 年的 13.9 億美元成長到 2033 年的 25.4 億美元，在預測期（2026-2033 年）內複合年成長率為 7.8%。

微流體免疫檢測市場正經歷顯著成長，其主要驅動力是資源匱乏地區改善患者照護的需求。人口結構變化以及對經濟高效、高通量診斷解決方案日益成長的需求，正推動照護現場（POC）在醫院、診所和家庭中的廣泛應用。儘管目前的POC設備仍面臨一些挑戰，例如需要檢體預處理和結果不穩定，但微型化的晶片實驗室（LOC）系統已成為主流。這些系統具有試劑消費量少、結果更快更準確等優點。推動市場擴張的因素包括：微流體技術研究的不斷深入、創業投資投資對基於LOC的診斷技術的投資不斷成長、急診護理中對快速決策的需求，以及老齡化社會中慢性病患病率的上升。

推動全球微流體免疫檢測市場發展的因素

受多種因素驅動，尤其是在新興經濟體，全球微流體免疫檢測市場預計將迎來顯著成長。紙基微流體技術等創新技術進一步拓展了市場機會。人口老化以及大量感染疾病和非傳染性疾病患者也推動了這一成長。此外，研發投入的增加、對高品質醫療服務需求的成長、可支配收入的提高以及醫療基礎設施的進步，都為微流體免疫檢測市場的發展創造了有利環境。

全球微流體免疫檢測市場面臨的限制因素

全球微流體免疫檢測市場面臨許多可能阻礙其成長的重大挑戰。其中一項主要挑戰是選擇合適的基底材料，這對於微流體晶片的製造至關重要。此外，複雜的健保報銷流程也為製造商帶來挑戰。擴大生產規模以滿足大眾市場需求同樣是一大障礙，開發價格適中、能夠滿足經濟發展中地區需求的產品也至關重要。解決這些限制因素對於充分發揮這項創新市場的潛力並使其惠及更多用戶至關重要。

全球微流體免疫檢測市場趨勢

全球微流體免疫檢測市場正經歷顯著的成長趨勢，這主要得益於晶片實驗室（LOC）技術的日益普及。 LOC技術將複雜的實驗室流程整合到小型設備中，不僅提高了便攜性，還減少了對傳統大規模設備的依賴。特別是紙基微流體控裝置，因其成本效益和多功能性，尤其在開發中國家的即時偵測（POC）應用中備受關注。紙基微流控裝置無需外力即可透過毛細作用移動流體，因此在學術界和商業領域都得到了廣泛的研究，使其成為各種醫療診斷應用的實用解決方案，並有助於改善醫療保健服務的可及性。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Abbott Laboratories（US）
Bio-Rad Laboratories（US）
Becton, Dickinson and Company（US）
Danaher Corporation（US）
Fluidigm Corporation（US）
GE Healthcare（US）
Illumina Inc.（US）
Luminex Corporation（US）
Merck Millipore（Germany）
PerkinElmer Inc.（US）
Randox Laboratories Ltd.（UK）
Roche Diagnostics（Switzerland）
Siemens Healthineers AG（Germany）
Thermo Fisher Scientific Inc.（US）
Tosoh Corporation（Japan）
Wako Pure Chemical Industries, Ltd.（Japan）
Waters Corporation（US）

結論與建議

簡介目錄

Product Code: SQMIG35H2075

Global Microfluidic Immunoassay Market size was valued at USD 1.29 Billion in 2024 and is poised to grow from USD 1.39 Billion in 2025 to USD 2.54 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The microfluidic immunoassay market is experiencing significant growth, driven by the need for improved patient care in resource-limited settings. Point-of-care (POC) testing is becoming increasingly accessible in hospitals, clinics, and homes, fueled by demographic changes and a demand for cost-effective, high-throughput diagnostic solutions. Despite ongoing challenges with current POC devices-such as sample pre-treatment requirements and inconsistent results-there is a notable shift towards miniaturized, lab-on-a-chip (LOC) systems. These systems offer advantages like reduced reagent consumption and rapid, accurate results. Factors contributing to market expansion include increased research in microfluidic technology, substantial venture capital investments in LOC-based diagnostics, the urgency of rapid decision-making in emergency care, and the rising prevalence of chronic diseases among the aging population.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidic Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidic Immunoassay Market Segments Analysis

Global Microfluidic Immunoassay Market is segmented by Product, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables, Cartridges, Polymer, Glass, Silicon, Reagents and Systems. Based on Technology, the market is segmented into Electrochemical Detection and Optical Detection. Based on Application, the market is segmented into Cardiology, Single Biomarker Detection, Multiplexed Biomarker Detection, Infectious Diseases, Oncology and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Hospital and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microfluidic Immunoassay Market

The global microfluidic immunoassay market is poised for significant growth driven by various factors, particularly in emerging economies. Opportunities for expansion are enhanced by innovative technologies, such as paper-based microfluidics. Contributing to this growth are demographics characterized by an aging population alongside a large number of patients affected by both infectious and non-communicable diseases. Furthermore, increased funding for research and development, coupled with rising demand for high-quality healthcare services, greater disposable incomes, and advancements in healthcare infrastructure, collectively foster a favorable environment for the microfluidic immunoassay market to thrive.

Restraints in the Global Microfluidic Immunoassay Market

The Global Microfluidic Immunoassay market faces several significant challenges that can impede its growth. One of the primary issues is the selection of appropriate substrate materials essential for the fabrication of microfluidic chips. Additionally, navigating the complexities of reimbursement processes can pose difficulties for manufacturers. Scaling production to meet mass-market demands remains another critical hurdle, as does the necessity to develop affordable products that can cater to the needs of less economically developed regions. Addressing these constraints is vital for maximizing the potential of this innovative market and ensuring broad accessibility to its benefits.

Market Trends of the Global Microfluidic Immunoassay Market

The Global Microfluidic Immunoassay market is experiencing a notable trend driven by the increasing adoption of lab-on-chip (LOC) technology, which consolidates complex laboratory processes onto compact devices. This shift not only enhances portability but also reduces reliance on traditional bulky equipment. Particularly, paper-based microfluidic devices are garnering significant attention, especially for point-of-care (POC) applications in developing nations, owing to their cost-effectiveness and versatility. With the ability to facilitate fluid movement through capillary action without external forces, paper substrates are being extensively explored in both academic and commercial sectors, positioning themselves as a viable solution for various medical diagnostics and enhancing accessibility in healthcare.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global Microfluidic Immunoassay Market Size by Product & CAGR (2026-2033)

Market Overview
Consumables
Cartridges
Polymer
Glass
Silicon
Reagents
Systems

Global Microfluidic Immunoassay Market Size by Technology & CAGR (2026-2033)

Market Overview
Electrochemical Detection
Optical Detection

Global Microfluidic Immunoassay Market Size by Application & CAGR (2026-2033)

Market Overview
Cardiology
Single Biomarker Detection
Multiplexed Biomarker Detection
Infectious Diseases
Oncology
Other Applications

Global Microfluidic Immunoassay Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
Hospital
Other End Users

Global Microfluidic Immunoassay Market Size & CAGR (2026-2033)

North America (Product, Technology, Application, End User)
- US
- Canada
Europe (Product, Technology, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Technology, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Millipore (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tosoh Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wako Pure Chemical Industries, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments